---
title: "Medical Device Software Vendors: FDA 510(k) Documentation Requirements"
keywords: "medical device software vendor, FDA 510k documentation, SaMD vendor selection, medical device software compliance, FDA software validation vendor"
buyer_stage: "Decision"
target_persona: "Compliance Officer"
---

# Medical Device Software Vendors: FDA 510(k) Documentation Requirements

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "headline": "Medical Device Software Vendors: FDA 510(k) Documentation Requirements",
  "description": "What compliance officers need to verify before hiring a software vendor to build or maintain Software as a Medical Device destined for FDA 510(k) clearance.",
  "author": {"@type": "Organization", "name": "Manifera", "url": "https://www.manifera.com/"},
  "publisher": {"@type": "Organization", "name": "Manifera", "url": "https://www.manifera.com/"},
  "datePublished": "2026-09-03",
  "mainEntityOfPage": {"@type": "WebPage", "@id": "https://www.manifera.com/blog/medical-device-software-vendors-fda-510k-documentation-requirements"}
}
</script>

A founder once told us their previous vendor had "basically already built an FDA-cleared product" — the software worked, it did what a Class II diagnostic aid was supposed to do, and clearance felt like a formality left for later. Eighteen months and one failed submission later, the company learned that FDA doesn't clear software; it clears documentation about software, and the documentation their vendor never produced — a Design History File, a software requirements traceability matrix, verification and validation test records tied to specific requirements — cannot be reconstructed retroactively with any credibility. They rebuilt the documentation trail from scratch, at a cost roughly triple what it would have cost to build it correctly from day one.

Choosing a vendor to build Software as a Medical Device (SaMD) is a documentation decision as much as an engineering one. A vendor who writes clean, working code but doesn't understand FDA's expectations around design controls and traceability isn't building you a medical device — they're building you a product you'll have to re-document before you can submit it.

## What "FDA-Cleared" Actually Means (and Doesn't)

510(k) clearance is a premarket notification process, not an approval — it requires demonstrating "substantial equivalence" to a legally marketed predicate device, not proving safety and efficacy from scratch the way a PMA (premarket approval) for Class III devices does. Most SaMD lands in Class II, cleared through 510(k), which means the vendor's job is to build something functionally and technologically comparable to an already-cleared predicate while documenting differences and their safety implications. A vendor who doesn't ask early "what's our predicate device, and how are we similar or different" is not thinking about this correctly — predicate selection shapes the entire documentation strategy.

## The 510(k) Documentation Vendors Must Produce

FDA's 2023 guidance on premarket software documentation splits submissions into Basic and Enhanced Documentation levels based on risk. Enhanced Documentation — required for higher-risk software functions, including most Class II SaMD with meaningful clinical impact — requires substantially more than Basic: a full Software Requirements Specification, Software Design Specification, architecture diagrams, a traceability matrix linking requirements to design elements to test cases to risk mitigations, and detailed verification and validation testing records including edge cases and off-nominal conditions.

A vendor building toward Enhanced Documentation needs to structure development around traceability from day one — user needs trace to design inputs, design inputs trace to design outputs, design outputs trace to verification tests, and verification links to risk analysis. Retrofitting this after the fact, as the founder above learned, means reconstructing intent for decisions already made, which regulatory reviewers and auditors can usually tell apart from documentation written contemporaneously.

## IEC 62304 and Design History File Ownership

IEC 62304 is the internationally recognized standard for medical device software lifecycle processes, and FDA reviewers expect submissions to reflect its structure even when not explicitly required — software safety classification (Class A, B, or C based on potential harm), a defined software development plan, and documented verification activities appropriate to that classification. A vendor unfamiliar with IEC 62304 will typically use their own generic SDLC (Scrum, Kanban, whatever) without adapting it to produce the specific artifacts a Design History File requires.

This raises a contractual question that's easy to skip past: who owns the Design History File (DHF) at contract end? The DHF is the compiled record proving your device was designed and developed under a controlled process — it belongs to you as the manufacturer of record, not to the vendor, and needs to transfer completely and legibly if you switch vendors or bring development in-house later. Specify DHF ownership and transfer format explicitly in the contract before development starts, not after a vendor relationship ends.

## Cybersecurity Documentation Since Section 524B

Since the FD&C Act's Section 524B took effect in 2023 (via the omnibus PATCH Act provisions), FDA requires cybersecurity information as part of premarket submissions for connected devices: a plan for monitoring and addressing post-market vulnerabilities, a process for providing patches and updates, and — critically — a Software Bill of Materials (SBOM) listing all commercial, open-source, and off-the-shelf software components in the device. A vendor building your SaMD needs to maintain an accurate, current SBOM as a standard deliverable, not a one-time export generated under deadline pressure before submission. Ask how they track third-party library versions and known vulnerabilities (CVE monitoring) throughout development — this becomes part of your regulatory submission, not just an engineering nicety.

## Red Flags in a Vendor's Regulatory Posture

Watch for a few specific tells: a vendor who describes their process as "FDA-ready" without being able to name IEC 62304 or ISO 14971 (risk management for medical devices) specifically; a vendor who treats documentation as something to compile at the end rather than maintain continuously; an inability to produce a sample traceability matrix from a prior project (with client details redacted); and — most tellingly — a vendor who's never actually taken a product through a completed 510(k) submission with a named regulatory consultant or in-house regulatory affairs lead involved. Software engineering competence and medical device regulatory competence are different skills, and the best vendors are explicit about which one they bring versus which one you need to source separately (a regulatory consultant or your own RA function).

## Vendor Questions Before You Commit

Ask directly: which documentation level (Basic or Enhanced) does their default process target, and can they adjust based on your device's risk classification? How do they structure requirements traceability in their tooling — a dedicated ALM platform like Jama or Polarion, or a homegrown spreadsheet system? Who owns and maintains the SBOM across the product lifecycle? What's their experience with FDA's Quality Management System Regulation (QMSR), which replaced the older 21 CFR Part 820 to harmonize with ISO 13485? A vendor with real answers to these will sound noticeably different from one improvising in the room. For teams building the underlying application alongside the regulatory documentation trail, [Manifera's custom software development](https://www.manifera.com/services/custom-software-development/) practice structures delivery around traceable requirements from the start specifically because retrofitting a Design History File is expensive and often not fully credible to reviewers.

## Making the Call

The right vendor for SaMD development is the one whose engineering process was designed around producing FDA documentation as a byproduct of how they build, not as a separate compliance exercise bolted on before submission. That means traceability tooling from day one, a clear answer on DHF ownership, and continuous SBOM maintenance rather than a scramble before filing. If your platform also needs to satisfy HIPAA obligations for any PHI it processes alongside its regulated device functions, our companion article on [BAA clauses that actually protect you](https://www.manifera.com/blog/hipaa-compliant-software-vendors-the-baa-clauses-that-actually-protect-you) covers that adjacent due diligence. Manifera's [approach to engagements](https://www.manifera.com/about-us/our-way-of-working/) treats regulatory documentation as a first-class deliverable for medical device software clients, not an afterthought.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ItemList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "Design History File (DHF)",
      "description": "The compiled documentation record proving a medical device was designed and developed under a controlled process, including requirements, design outputs, verification, and validation records. It belongs to the manufacturer of record and must transfer completely if the vendor relationship ends."
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Software Bill of Materials (SBOM)",
      "description": "A required inventory of all commercial, open-source, and off-the-shelf software components in a connected medical device, maintained continuously to support FDA's Section 524B cybersecurity submission requirements and post-market vulnerability monitoring."
    }
  ]
}
</script>

## Frequently Asked Questions

### Does a 510(k) clearance mean the FDA "approved" the software?
No. 510(k) is a clearance based on demonstrating substantial equivalence to an already-marketed predicate device, not an approval based on independent proof of safety and efficacy. That distinction affects the documentation strategy — predicate selection and comparison become central to the submission.

### What's the difference between Basic and Enhanced Documentation levels?
FDA's 2023 software guidance defines Basic Documentation for lower-risk software functions and Enhanced Documentation for higher-risk ones, with Enhanced requiring substantially more detail: full requirements specifications, design specifications, architecture documentation, and a complete traceability matrix linking requirements through testing.

### Who should own the Design History File if we switch vendors?
The manufacturer of record — typically you, the company seeking clearance — should own the DHF regardless of which vendor built the software. This should be specified explicitly in the vendor contract, including the format and completeness of the transfer, before development begins.

### Do we need a separate regulatory consultant if our vendor understands FDA requirements?
Usually yes. Software engineering competence and regulatory affairs competence are different skills; even a vendor experienced in producing traceable, compliant documentation is typically not the party who should be making final regulatory strategy decisions or signing the submission. Most successful submissions involve a dedicated regulatory consultant or in-house RA function working alongside the development vendor.

### What is an SBOM and why does a software vendor need to maintain one?
A Software Bill of Materials is an inventory of every software component — commercial, open-source, and third-party — in the device, required under FDA's Section 524B cybersecurity provisions. It needs continuous maintenance throughout development, not a one-time snapshot, because it directly supports post-market vulnerability monitoring obligations.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Does a 510(k) clearance mean the FDA \"approved\" the software?",
      "acceptedAnswer": {"@type": "Answer", "text": "No. 510(k) is a clearance based on demonstrating substantial equivalence to an already-marketed predicate device, not an approval based on independent proof of safety and efficacy. That distinction affects the documentation strategy, since predicate selection and comparison become central to the submission."}
    },
    {
      "@type": "Question",
      "name": "What's the difference between Basic and Enhanced Documentation levels?",
      "acceptedAnswer": {"@type": "Answer", "text": "FDA's 2023 software guidance defines Basic Documentation for lower-risk software functions and Enhanced Documentation for higher-risk ones, with Enhanced requiring substantially more detail, including full requirements specifications, design specifications, architecture documentation, and a complete traceability matrix linking requirements through testing."}
    },
    {
      "@type": "Question",
      "name": "Who should own the Design History File if we switch vendors?",
      "acceptedAnswer": {"@type": "Answer", "text": "The manufacturer of record, typically the company seeking clearance, should own the DHF regardless of which vendor built the software. This should be specified explicitly in the vendor contract, including the format and completeness of the transfer, before development begins."}
    },
    {
      "@type": "Question",
      "name": "Do we need a separate regulatory consultant if our vendor understands FDA requirements?",
      "acceptedAnswer": {"@type": "Answer", "text": "Usually yes. Software engineering competence and regulatory affairs competence are different skills; even a vendor experienced in producing traceable, compliant documentation is typically not the party who should be making final regulatory strategy decisions or signing the submission."}
    },
    {
      "@type": "Question",
      "name": "What is an SBOM and why does a software vendor need to maintain one?",
      "acceptedAnswer": {"@type": "Answer", "text": "A Software Bill of Materials is an inventory of every software component, commercial, open-source, and third-party, in the device, required under FDA's Section 524B cybersecurity provisions. It needs continuous maintenance throughout development, not a one-time snapshot, because it directly supports post-market vulnerability monitoring obligations."}
    }
  ]
}
</script>
